{"id":"W4402661363","doi":"10.1016/j.annonc.2024.08.2339","title":"First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Loxo Oncology; University of Texas MD Anderson Cancer Center; Amgen; Pfizer; Symphogen; GlaxoSmithKline","keywords":"Protein arginine methyltransferase 5; Medicine; Maximum tolerated dose; Cancer research; Arginine; Pharmacology; Methyltransferase; Biochemistry; Pharmacokinetics; Amino acid; Biology; Methylation; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00230026,0.002001437,0.003292158,0.0006796093,0.0008569974,0.001854347,0.00115947,0.001560344,0.004013973],"category_scores_gemma":[0.001199504,0.00066177,0.002675581,0.0008093289,0.001602028,0.001249094,0.0004902754,0.003992183,0.001112502],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001738869,"about_ca_system_score_gemma":0.002150474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004931209,"about_ca_topic_score_gemma":0.008269306,"domain_scores_codex":[0.9991257,0.0004130137,0.00003402051,0.0001128034,0.00006159356,0.0002529436],"domain_scores_gemma":[0.9988612,0.0002775556,0.0001489155,0.0001891597,0.0000594835,0.0004635899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5024547,0.1300521,0.02240852,0.001079252,0.00513503,0.001000326,0.001105094,0.00783589,0.07817535,0.0009509382,0.01181224,0.2379905],"study_design_scores_gemma":[0.2023791,0.7264859,0.02518413,0.0001077872,0.003019092,0.0009336338,0.0003058098,0.002052564,0.02484421,0.001051927,0.01353431,0.0001015949],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979879,0.006821839,0.002223093,0.001001276,0.0001511395,0.001424439,0.003735374,0.0002651449,0.004498568],"genre_scores_gemma":[0.9794068,0.006343756,0.002379877,0.001309716,0.000198924,0.001318361,0.004393934,0.0001824858,0.004466015],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004931209,"threshold_uncertainty_score":0.01342809,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04062427101121577,"score_gpt":0.36532275548837,"score_spread":0.3246984844771542,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}